CAS 349085-82-1

4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide

Description:

4-Methoxy-N-(2,4,6-trimethylphenyl)benzenesulfonamide, identified by its CAS number 349085-82-1, is an organic compound characterized by its sulfonamide functional group, which is known for its applications in pharmaceuticals and agrochemicals. This compound features a methoxy group (-OCH3) and a tri-substituted methylphenyl moiety, contributing to its unique chemical properties. The presence of the sulfonamide group imparts potential biological activity, making it of interest in medicinal chemistry. The compound is likely to exhibit moderate solubility in organic solvents due to its hydrophobic aromatic structure, while the methoxy group may enhance its solubility in polar solvents. Additionally, the steric hindrance introduced by the trimethyl groups can influence its reactivity and interaction with biological targets. Overall, this compound's structural characteristics suggest potential utility in various chemical applications, particularly in the development of new therapeutic agents. However, specific safety and handling information should be consulted from material safety data sheets (MSDS) or relevant literature before use.

GSK137647A

CAS: 349085-82-1

Formula: C₁₆H₁₉NO₃S

Purity: 98%

Color and Shape: Solid

Molecular weight: 305.3920

Ref: IN-DA00C6LA

Gsk137647A

CAS: 349085-82-1

Gsk137647A

Purity: 99%

Molecular weight: 305.39g/mol

Ref: 54-OR1013441

GSK137647A

CAS: 349085-82-1

GSK137647A

Purity: ≥98%

Molecular weight: 305.39g/mol

Ref: 54-BUP13041

GSK137647A

CAS: 349085-82-1

GSK137647A (GSK 137647) is a selective FFA4 agonist.

Formula: C₁₆H₁₉NO₃S

Purity: 99.26% - >99.99%

Color and Shape: Solid

Molecular weight: 305.39

Ref: TM-T3171

GSK 137647A

CAS: 349085-82-1

GSK 137647A is an investigational pharmaceutical compound, which is a selective agonist sourced from GlaxoSmithKline's research laboratories. Its mode of action involves the stimulation of beta-3 adrenergic receptors, which are primarily located in adipose tissue and, notably, in cardiac tissue. This receptor activation leads to increased lipolysis and thermogenesis in adipose tissues, while in the cardiac tissue, it modulates heart function.

Formula: C₁₆H₁₉NO₃S

Purity: Min. 95%

Molecular weight: 305.39 g/mol

Ref: 3D-ZNA08582